Canada Life’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.24M Sell
94,709
-1,547
-2% -$80.8K 0.01% 658
2025
Q4
$4.07M Hold
96,256
0.01% 836
2025
Q3
$3.93M Buy
96,256
+1,708
+2% +$85K 0.01% 924
2025
Q2
$5.23M Sell
94,548
-1,842
-2% -$91.8K 0.01% 767
2025
Q1
$5.48M Buy
96,390
+54,927
+132% +$3.43M 0.01% 756
2024
Q4
$2.87M Sell
41,463
-19,413
-32% -$1.87M ﹤0.01% 1104
2024
Q3
$8.29M Buy
60,876
+3,311
+6% +$435K 0.01% 635
2024
Q2
$7.77M Sell
57,565
-2,016
-3% -$308K 0.01% 635
2024
Q1
$10.2M Buy
59,581
+930
+2% +$142K 0.02% 555
2023
Q4
$9.07M Sell
58,651
-706
-1% -$92.1K 0.02% 557
2023
Q3
$7.45M Sell
59,357
-1,561
-3% -$192K 0.02% 589
2023
Q2
$7.09M Buy
60,918
+5,630
+10% +$610K 0.02% 602
2023
Q1
$6.03M Sell
55,288
-1,256
-2% -$145K 0.02% 666
2022
Q4
$5.81M Buy
56,544
+1,148
+2% +$114K 0.02% 667
2022
Q3
$5M Sell
55,396
-9,848
-15% -$1.08M 0.01% 683
2022
Q2
$7.68M Sell
65,244
-10,656
-14% -$1.53M 0.02% 590
2022
Q1
$11.5M Sell
75,900
-863
-1% -$132K 0.02% 540
2021
Q4
$12.9M Sell
76,763
-1,664
-2% -$271K 0.03% 528
2021
Q3
$11.9M Sell
78,427
-1,570
-2% -$242K 0.03% 529
2021
Q2
$12.1M Sell
79,997
-607
-0.8% -$96.4K 0.03% 543
2021
Q1
$12M Buy
80,604
+2,088
+3% +$287K 0.03% 550
2020
Q4
$10.2M Buy
78,516
+1,231
+2% +$153K 0.02% 611
2020
Q3
$8.31M Sell
77,285
-792
-1% -$79K 0.02% 581
2020
Q2
$6.72M Sell
78,077
-116,117
-60% -$9.68M 0.02% 623
2020
Q1
$14.3M Buy
194,194
+8,935
+5% +$884K 0.04% 379
2019
Q4
$22.6M Sell
185,259
-53,577
-22% -$6.59M 0.05% 358
2019
Q3
$29.3M Sell
238,836
-4,978
-2% -$561K 0.07% 299
2019
Q2
$26.3M Sell
243,814
-5,977
-2% -$619K 0.06% 323
2019
Q1
$24.6M Buy
249,791
+167,206
+202% +$16.4M 0.07% 282
2018
Q4
$7.08M Buy
82,585
+15,638
+23% +$1.53M 0.02% 547
2018
Q3
$7.64M Sell
66,947
-12,651
-16% -$1.45M 0.02% 576
2018
Q2
$8.84M Sell
79,598
-42,429
-35% -$4.68M 0.02% 565
2018
Q1
$12.2M Buy
122,027
+7,972
+7% +$841K 0.03% 459
2017
Q4
$12.2M Sell
114,055
-6,026
-5% -$640K 0.03% 471
2017
Q3
$12.5M Sell
120,081
-86
-0.1% -$8.45K 0.03% 453
2017
Q2
$11.4M Buy
120,167
+39,409
+49% +$3.51M 0.03% 466
2017
Q1
$7.25M Sell
80,758
-2,331
-3% -$204K 0.02% 585
2016
Q4
$6.56M Sell
83,089
-1,284
-2% -$96.5K 0.02% 605
2016
Q3
$5.61M Sell
84,373
-6,453
-7% -$422K 0.02% 647
2016
Q2
$5.93M Buy
90,826
+9,509
+12% +$661K 0.02% 618
2016
Q1
$5.32M Sell
81,317
-1,791
-2% -$111K 0.02% 574
2015
Q4
$5.6M Sell
83,108
-745
-0.9% -$50.6K 0.02% 553
2015
Q3
$4.97M Buy
83,853
+6,597
+9% +$418K 0.02% 568
2015
Q2
$5.54M Buy
77,256
+3,027
+4% +$201K 0.02% 594
2015
Q1
$4.14M Sell
74,229
-4,942
-6% -$280K 0.01% 671
2014
Q4
$4.74M Sell
79,171
-42,210
-35% -$2.47M 0.02% 624
2014
Q3
$7.13M Sell
121,381
-56,684
-32% -$3.49M 0.02% 512
2014
Q2
$11.4M Sell
178,065
-12,188
-6% -$740K 0.04% 397
2014
Q1
$10.5M Buy
190,253
+1,644
+0.9% +$87.6K 0.04% 403
2013
Q4
$10.5M Sell
188,609
-53,248
-22% -$2.95M 0.04% 406
2013
Q3
$12.7M Buy
+241,857
New +$11.8M 0.05% 337

Other funds holding CE

Canada Life's CE Position: Q1 2026 in Review

Canada Life reduced its Celanese (CE) stake by 1.6% in Q1 2026, selling an estimated $80.8K and leaving 94,709 shares worth $6.24M. The position accounts for 0.01% of the portfolio, ranked #658.

Canada Life first reported a position in CE in Q3 2013 and has held it in 51 quarters since. The position peaked at $29.3M in Q3 2019. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Canada Life held 94,709 shares of Celanese worth $6.24M as of Q1 2026.
  • Canada Life sold 1,547 Celanese shares in Q1 2026, an estimated $80.8K.
  • Celanese made up 0.01% of Canada Life's portfolio in Q1 2026, its #658 holding.
  • Canada Life first reported a position in Celanese in Q3 2013 and has held it in 51 quarters since.
  • Canada Life's Celanese position peaked at $29.3M in Q3 2019.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.